Latham & Watkins Advises on LeMaitre’s US$150 Million Convertible Senior Notes Offering

LeMaitre Vascular, Inc. (LeMaitre) (Nasdaq: LMAT) has announced the pricing of its offering of US$150,000,000 aggregate principal amount of 2.50% Convertible Senior Notes due 2030 (the notes) in a private offering (the offering) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. The issuance and sale of the notes is scheduled to settle on December 19, 2024, subject to customary closing conditions. LeMaitre also granted the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional US$22,500,000 aggregate principal amount of notes.

Latham & Watkins LLP represented the initial purchasers in the offering with a capital markets team led by New York partners Nathan Ajiashvili and Reza Mojtabaee-Zamani, and counsel Lindsey Mills, with associates Isabelle Sawhney, Sloan Ungerman, and Daniel Weiss.